Skip to Content
Merck

Warmth Prevents Bone Loss Through the Gut Microbiota.

Cell metabolism (2020-09-12)
Claire Chevalier, Silas Kieser, Melis Çolakoğlu, Noushin Hadadi, Julia Brun, Dorothée Rigo, Nicolas Suárez-Zamorano, Martina Spiljar, Salvatore Fabbiano, Björn Busse, Julijana Ivanišević, Andrew Macpherson, Nicolas Bonnet, Mirko Trajkovski
ABSTRACT

Osteoporosis is the most prevalent metabolic bone disease, characterized by low bone mass and microarchitectural deterioration. Here, we show that warmth exposure (34°C) protects against ovariectomy-induced bone loss by increasing trabecular bone volume, connectivity density, and thickness, leading to improved biomechanical bone strength in adult female, as well as in young male mice. Transplantation of the warm-adapted microbiota phenocopies the warmth-induced bone effects. Both warmth and warm microbiota transplantation revert the ovariectomy-induced transcriptomics changes of the tibia and increase periosteal bone formation. Combinatorial metagenomics/metabolomics analysis shows that warmth enhances bacterial polyamine biosynthesis, resulting in higher total polyamine levels in vivo. Spermine and spermidine supplementation increases bone strength, while inhibiting polyamine biosynthesis in vivo limits the beneficial warmth effects on the bone. Our data suggest warmth exposure as a potential treatment option for osteoporosis while providing a mechanistic framework for its benefits in bone disease.

MATERIALS
Product Number
Brand
Product Description

Supelco
Metronidazole, analytical standard
Sigma-Aldrich
Naphthol AS-TR phosphate disodium salt, ≥99% (HPLC), Bulk package
Sigma-Aldrich
Spermidine, ≥99% (GC)
Sigma-Aldrich
Vancomycin hydrochloride from Streptomyces orientalis, ≥900 μg per mg (as vancomycin base)
Sigma-Aldrich
Human Osteocalcin ELISA Kit, for cell culture supernatants, plasma, and serum samples